US3773919A
(en)
|
1969-10-23 |
1973-11-20 |
Du Pont |
Polylactide-drug mixtures
|
US4190328A
(en)
|
1978-12-01 |
1980-02-26 |
Levine Robert A |
Process for detection of blood-borne parasites
|
DE2928477C3
(de)
*
|
1979-07-14 |
1982-04-15 |
Battelle-Institut E.V., 6000 Frankfurt |
Vorrichtung zur Freisetzung von Substanzen an definierten Orten des Verdauungstraktes
|
US4522811A
(en)
|
1982-07-08 |
1985-06-11 |
Syntex (U.S.A.) Inc. |
Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
|
US4816567A
(en)
|
1983-04-08 |
1989-03-28 |
Genentech, Inc. |
Recombinant immunoglobin preparations
|
US4676980A
(en)
|
1985-09-23 |
1987-06-30 |
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Target specific cross-linked heteroantibodies
|
US4987071A
(en)
|
1986-12-03 |
1991-01-22 |
University Patents, Inc. |
RNA ribozyme polymerases, dephosphorylases, restriction endoribonucleases and methods
|
US5116742A
(en)
|
1986-12-03 |
1992-05-26 |
University Patents, Inc. |
RNA ribozyme restriction endoribonucleases and methods
|
US4904582A
(en)
|
1987-06-11 |
1990-02-27 |
Synthetic Genetics |
Novel amphiphilic nucleic acid conjugates
|
JP2681061B2
(ja)
|
1988-06-08 |
1997-11-19 |
ロンドン・ダイアグノスティック・インコーポレーテッド |
検出可能なシグナルのセンシタイザー誘導発生を利用したアッセイ
|
US6251581B1
(en)
|
1991-05-22 |
2001-06-26 |
Dade Behring Marburg Gmbh |
Assay method utilizing induced luminescence
|
US5314805A
(en)
|
1991-10-28 |
1994-05-24 |
Molecular Probes, Inc. |
Dual-fluorescence cell viability assay using ethidium homodimer and calcein AM
|
US5596090A
(en)
|
1992-07-24 |
1997-01-21 |
The United States Of America As Represented By The Secretary Of The Navy |
Antisense oligonucleotides directed against human VCAM-1 RNA
|
PT1498427E
(pt)
|
1992-08-21 |
2010-03-22 |
Univ Bruxelles |
Imunoglobulinas desprovidas de cadeias leves
|
US5731168A
(en)
|
1995-03-01 |
1998-03-24 |
Genentech, Inc. |
Method for making heteromultimeric polypeptides
|
US6267958B1
(en)
|
1995-07-27 |
2001-07-31 |
Genentech, Inc. |
Protein formulation
|
US5763602A
(en)
|
1996-10-01 |
1998-06-09 |
Li; Ying-Syi |
Methods of syntheses of phthalocyanine compounds
|
US5919792A
(en)
|
1996-10-30 |
1999-07-06 |
Merck & Co., Inc. |
Integrin antagonists
|
AU6780398A
(en)
|
1997-03-28 |
1998-10-22 |
Du Pont Merck Pharmaceutical Company, The |
Heterocyclic integrin inhibitor prodrugs
|
US6171586B1
(en)
|
1997-06-13 |
2001-01-09 |
Genentech, Inc. |
Antibody formulation
|
US6630492B1
(en)
|
1997-08-28 |
2003-10-07 |
Novartis Ag |
Lymphocyte function antigen-1 antagonists
|
US6506559B1
(en)
|
1997-12-23 |
2003-01-14 |
Carnegie Institute Of Washington |
Genetic inhibition by double-stranded RNA
|
WO1999042838A1
(en)
|
1998-02-18 |
1999-08-26 |
Dade Behring Inc. |
Chemiluminescent compositions for use in detection of multiple analytes
|
US6833373B1
(en)
|
1998-12-23 |
2004-12-21 |
G.D. Searle & Co. |
Method of using an integrin antagonist and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia
|
EP1144388B1
(en)
|
1999-01-22 |
2010-01-13 |
Elan Pharmaceuticals, Inc. |
Acyl derivatives which treat vla-4 related disorders
|
US8636648B2
(en)
*
|
1999-03-01 |
2014-01-28 |
West View Research, Llc |
Endoscopic smart probe
|
US6331530B1
(en)
|
1999-07-13 |
2001-12-18 |
The Trustees Of Columbia University In The City Of New York |
Hydrophilic carrier for photosensitizers that cleaves when they catalyze the formation of singlet oxygen
|
US6703248B1
(en)
|
1999-12-15 |
2004-03-09 |
Dade Behring Marburg Gmbh |
Particles for diagnostic and therapeutic use
|
JP4039856B2
(ja)
|
2000-02-03 |
2008-01-30 |
エーザイ・アール・アンド・ディー・マネジメント株式会社 |
インテグリン発現阻害剤
|
JP2003523768A
(ja)
|
2000-02-25 |
2003-08-12 |
イミュネックス・コーポレーション |
インテグリンアンタゴニスト
|
WO2001068586A2
(en)
|
2000-03-14 |
2001-09-20 |
Novartis Ag |
α4β1 AND α4β7 INTEGRIN INHIBITORS
|
US6794506B2
(en)
|
2000-07-21 |
2004-09-21 |
Elan Pharmaceuticals, Inc. |
3-(heteroaryl) alanine derivatives-inhibitors of leukocyte adhesion mediated by VLA-4
|
DE10040105A1
(de)
|
2000-08-17 |
2002-02-28 |
Merck Patent Gmbh |
Peptid- und Peptidmimetika-Derivate mit Integrin-Inhibitor-Eigenschaften
|
DE10204789A1
(de)
|
2002-02-06 |
2003-08-14 |
Merck Patent Gmbh |
Inhibitoren des Integrins alpha¶v¶beta6
|
AU2003222253A1
(en)
|
2002-03-05 |
2003-09-22 |
Monogram Biosciences, Inc. |
Multiplex analysis using membrane-bound sensitizers
|
BRPI0308585B8
(pt)
|
2002-03-13 |
2021-05-25 |
Biogen Idec Inc |
anticorpo isolado ou fragmento de ligação a antígeno do mesmo que se liga à alfavbeta6, composição, método de detecção in vitro de alfavbeta6 e construção de dna
|
EP1519717B1
(en)
*
|
2002-07-05 |
2010-09-29 |
Temrel Limited |
Controlled release composition
|
US9211259B2
(en)
|
2002-11-29 |
2015-12-15 |
Foamix Pharmaceuticals Ltd. |
Antibiotic kit and composition and uses thereof
|
RU2334506C2
(ru)
*
|
2003-01-29 |
2008-09-27 |
И-Пилл Фарма Лтд. |
Активная доставка лекарственного средства в желудочно-кишечном тракте
|
DE10305784A1
(de)
|
2003-02-12 |
2004-08-26 |
Merck Patent Gmbh |
Verfahren zur Herstellug bicyclischer aromatischer Aminosäuren sowie deren Zwischenprodukte
|
US7871607B2
(en)
|
2003-03-05 |
2011-01-18 |
Halozyme, Inc. |
Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanases
|
US20060104968A1
(en)
|
2003-03-05 |
2006-05-18 |
Halozyme, Inc. |
Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminogly ycanases
|
US7402398B2
(en)
|
2003-07-17 |
2008-07-22 |
Monogram Biosciences, Inc. |
Measuring receptor homodimerization
|
AU2004275804A1
(en)
|
2003-09-23 |
2005-04-07 |
Light Sciences Oncology, Inc. |
Conjugates for photodynamic therapy
|
RU2388472C2
(ru)
|
2003-10-01 |
2010-05-10 |
Мерк Патент Гмбх |
Антагонисты альфаvбета3 и альфаvбета6 интегринов в качестве антифибротических агентов
|
EP1677783A2
(en)
|
2003-10-08 |
2006-07-12 |
Nicholas Piramal India Limited |
Fibrinogen receptor antagonists and their use
|
CN105820160B
(zh)
|
2003-11-05 |
2019-02-12 |
萨可德生物科学公司 |
细胞粘着调节剂
|
CA2559685A1
(en)
*
|
2004-03-26 |
2005-10-06 |
Lek Pharmaceuticals D.D. |
Gastroresistant pharmaceutical dosage form comprising n-(2-(2-phthalimidoethoxy)-acetyl)-l-alanyl-d-glutamic acid (lk-423)
|
JP2008510007A
(ja)
|
2004-08-16 |
2008-04-03 |
メディミューン,インコーポレーテッド |
抗体依存性細胞性細胞傷害活性が増強されたEph受容体Fc変異体
|
DK176145B1
(da)
|
2004-09-23 |
2006-10-02 |
Guldmann V As |
Kobling
|
JO3000B1
(ar)
|
2004-10-20 |
2016-09-05 |
Genentech Inc |
مركبات أجسام مضادة .
|
ITMI20050328A1
(it)
|
2005-03-03 |
2006-09-04 |
Univ Degli Studi Milano |
Composti peptidomimetrici e preparazione di derivati biologicamente attivi
|
WO2007054128A1
(en)
|
2005-11-14 |
2007-05-18 |
Dominion Pharmakine S.L. |
Novel inhibitors of the lfa-1/icam-1 interaction, and uses thereof
|
GB0507918D0
(en)
|
2005-04-19 |
2005-05-25 |
Novartis Ag |
Organic compounds
|
KR20080022552A
(ko)
|
2005-05-20 |
2008-03-11 |
엘란 파마슈티칼스, 인크. |
Vla―4 길항제로서의 이미다졸론 페닐알라닌 유도체
|
US7612181B2
(en)
|
2005-08-19 |
2009-11-03 |
Abbott Laboratories |
Dual variable domain immunoglobulin and uses thereof
|
EP2500352A1
(en)
|
2005-08-19 |
2012-09-19 |
Abbott Laboratories |
Dual variable domain immunoglobulin and uses thereof
|
GB0520378D0
(en)
|
2005-10-06 |
2005-11-16 |
Novartis Ag |
Organic compounds
|
EP2298308B1
(en)
|
2005-11-14 |
2013-01-16 |
University Of Southern California |
Integrin-binding small molecules
|
US8129366B2
(en)
|
2005-12-13 |
2012-03-06 |
Daiichi Sankyo Company, Limited |
VLA-4 inhibitory drug
|
MX2008010988A
(es)
|
2006-02-27 |
2008-10-20 |
Elan Pharm Inc |
Compuestos de pirimidinil sulfonamida que inhiben la adhesion de los leucocitos mediada por vla-4.
|
ES2544957T3
(es)
|
2006-03-21 |
2015-09-07 |
Genentech, Inc. |
Terapia combinada que implica antagonistas alfa5beta1
|
CH701730B1
(de)
|
2006-05-31 |
2011-03-15 |
Hanwha Chemical Corp |
VCAM-1 spezifischer monoklonaler Antikörper.
|
EP2046434B1
(en)
*
|
2006-06-23 |
2012-02-08 |
Koninklijke Philips Electronics N.V. |
Medicament delivery system
|
CA2658612C
(en)
|
2006-08-03 |
2015-11-17 |
Astrazeneca Ab |
Antibodies directed to .alpha.v.beta.6 and uses thereof
|
CA2675827A1
(en)
*
|
2007-02-26 |
2008-09-04 |
Duocure, Inc. |
Spray administration of compositions including active agents such as peptides to the gastrointestinal tract
|
CA2683415C
(en)
*
|
2007-04-04 |
2020-12-08 |
Sigmoid Pharma Limited |
An oral pharmaceutical composition
|
CA2693863C
(en)
|
2007-07-17 |
2017-10-03 |
Merck Patent Gmbh |
Engineered anti-alpha v- integrin hybrid antibodies
|
WO2009076434A1
(en)
|
2007-12-12 |
2009-06-18 |
Molecular Insight Pharmaceuticals, Inc. |
Inhibitors of integrin vla-4
|
WO2011004395A1
(en)
|
2009-07-06 |
2011-01-13 |
Intas Biopharmaceuticals Limited |
Microemulsion formulation for biologicals
|
JP6030956B2
(ja)
*
|
2009-08-05 |
2016-11-24 |
テル ハショマー メディカル リサーチ インフラストラクチャー アンド サーヴィシーズ リミテッド |
胃腸管の異常の診断に使える情報を提供する方法と機器
|
KR101277406B1
(ko)
|
2009-10-23 |
2013-06-21 |
한화케미칼 주식회사 |
Vcam-1에 특이적으로 결합하고 백혈구와 내피세포의 접착 및 투과를 저해하는 재조합 인간 단일클론항체
|
ITFI20100019A1
(it)
|
2010-02-12 |
2011-08-13 |
Univ Firenze |
Inibitori peptidomimetici di integrine basati sull'1,2,3-triazolo per la diagnosi e terapia dei tumori.
|
EP2547693B1
(en)
|
2010-03-19 |
2015-03-11 |
H. Lee Moffitt Cancer Center & Research Institute |
Integrin interaction inhibitors for the treatment of cancer
|
JP2013525435A
(ja)
|
2010-04-30 |
2013-06-20 |
エラン ファーマシューティカルズ,インコーポレイテッド |
選択的インテグリン阻害剤
|
US8907081B2
(en)
|
2011-05-27 |
2014-12-09 |
Sharp Laboratories Of America, Inc. |
Long wavelength absorbing porphyrin photosensitizers for dye-sensitized solar cells
|
MX352546B
(es)
|
2011-08-17 |
2017-11-29 |
Piramal Imaging Sa |
Compuesto para la union de glicoproteina iib/iiia especifica a plaquetas y su uso para la formacion de imagenes de un trombo.
|
FR2979346B1
(fr)
|
2011-08-23 |
2013-09-27 |
Univ Joseph Fourier |
Nanocorps anti-vcam-1
|
WO2013113326A1
(en)
|
2012-01-31 |
2013-08-08 |
Curevac Gmbh |
Pharmaceutical composition comprising a polymeric carrier cargo complex and at least one protein or peptide antigen
|
FR2986432B1
(fr)
|
2012-02-06 |
2014-03-14 |
Univ Lille Ii Droit & Sante |
Proteines 28kda gst provenant de schistosomes pour leur utilisation dans le traitement des maladies inflammatoires auto-immunes engendrant une reponse de type th1 et/ou th17
|
GB201207155D0
(en)
|
2012-04-24 |
2012-06-06 |
Isis Innovation |
Antibodies
|
US20140349944A1
(en)
|
2013-05-23 |
2014-11-27 |
Musc Foundation For Research Development |
Chaperone-based integrin inhibitors for the treatment of cancer and inflammatory diseases
|
MX367046B
(es)
|
2013-05-24 |
2019-08-02 |
Soc Des Produits Nestle S A Star |
Marcadores especificos de via para diagnosticar sindrome del intestino irritable.
|
JP6411342B2
(ja)
*
|
2013-07-03 |
2018-10-24 |
武田薬品工業株式会社 |
アミド化合物
|
CN111097097A
(zh)
*
|
2013-09-26 |
2020-05-05 |
宝珍那提公司 |
具有阈值释放装置的传送胶囊
|
US20160249793A1
(en)
*
|
2013-12-27 |
2016-09-01 |
Kang-Huai Wang |
Capsule Camera Device with Multi-Spectral Light Sources
|
KR102056963B1
(ko)
|
2013-12-30 |
2019-12-17 |
에피맙 바이오테라퓨틱스 인코포레이티드 |
Fabs-인-탠덤 면역글로불린 및 이의 용도
|
GB201400442D0
(en)
*
|
2014-01-10 |
2014-02-26 |
Sigmoid Pharma Ltd |
Compositions for use in the treatment of ulcerative colitis
|
WO2015112575A1
(en)
|
2014-01-22 |
2015-07-30 |
The Board Of Regents Of The University Of Nebraska |
Gastrointestinal sensor implantation system
|
ES2818823T3
(es)
*
|
2014-02-27 |
2021-04-14 |
Biogen Ma Inc |
Método de evaluación del riesgo de LMP
|
DE102014004843A1
(de)
|
2014-04-02 |
2015-10-08 |
Schaltbau Gmbh |
Gleichstromschütz mit zusätzlicher Schalttauglichkeit für Wechselstromlasten und Polung entgegen der Vorzugsstromrichtung
|
EP3179983A4
(en)
*
|
2014-08-13 |
2018-01-10 |
Cedars-Sinai Medical Center |
Anti-methanogenic compositions and uses thereof
|
SG11201702308TA
(en)
*
|
2014-09-25 |
2017-04-27 |
Progenity Inc |
Electromechanical pill device with localization capabilities
|
US9714288B2
(en)
|
2014-09-30 |
2017-07-25 |
The Regents Of The University Of California |
Antisense compounds and uses thereof
|
US9750923B2
(en)
*
|
2014-11-19 |
2017-09-05 |
Velóce Corporation |
Wireless communications system integrating electronics into orally ingestible products for controlled release of active ingredients
|
CN104473611B
(zh)
|
2015-01-19 |
2018-01-30 |
吉林大学 |
具有超声波定位功能的胶囊内窥镜系统
|
AU2016229976B2
(en)
*
|
2015-03-06 |
2021-11-11 |
Theriva Biologics, Inc. |
Safe and effective beta-lactamase dosing for microbiome protection
|
US11851214B2
(en)
|
2021-11-17 |
2023-12-26 |
H2 Clipper, Inc. |
System, method and apparatus for airship manufacture using robotics
|